Wassim Ghadban
Business Development Representative at BioRender- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Project Management Level One
UdemyJul, 2021- Nov, 2024 -
Biotechnology Start-up 101
National Research Council Canada / Conseil national de recherches CanadaOct, 2018- Nov, 2024
Experience
-
BioRender
-
Canada
-
Software Development
-
100 - 200 Employee
-
Business Development Representative
-
Oct 2021 - Present
BioRender is a web app that enables scientists in biotech, biopharma, and academia to create and share professional science figures in minutes! BioRender is a web app that enables scientists in biotech, biopharma, and academia to create and share professional science figures in minutes!
-
-
-
National Research Council Canada / Conseil national de recherches Canada
-
Canada
-
Research Services
-
700 & Above Employee
-
Student Research Scientist
-
May 2020 - Sep 2021
- I work in the department of human health therapeutics which creates and discovers innovative medicines to treat chronic diseases and facilitate the growth of Canadian Biotech SMEs.- I work with a team researching exosomes and their ability to deliver therapeutics to specific parts of the body.- I am in the process of publishing a scientific review paper that discusses exosomes’ ability to deliver therapeutics across the blood-brain barrier to treat neurological diseases.- I created a protocol for analyzing cellular images on an analytical software know as Image-pro. - I regularly give presentations to colleges on emerging technologies and therapeutics.
-
-
-
Capital Sealers Inc.
-
Canada
-
Construction
-
1 - 100 Employee
-
Director Of Operations
-
Jan 2018 - Sep 2021
Capital Sealers Inc. expertise is to restore and preserve exterior wooden structures such as log homes, decks, fences, and gazebos. Capital Sealers Inc. consists of 15 employees and provides services to over 150 homeowners in the Ottawa region annually. As the Director of Operations, I work to ensure that the company is running smoothly while maximizing efficiency and productivity. My responsibilities as the Director of Operations include:Developing and overseeing the implementation of the company's customer journey from first point of contact to final purchase of our services.Directly work with project managers to ensure that our client's projects are completed to the highest of quality. Developing and overseeing the implementation of the company's marketing and communications strategy which includes: social media marketing, SEO optimization, and Google AdWords. I ensure that the company achieves its sales and revenue targets by implementing strategic plans in order to close out sales during in-person quotes. Collaborate with management to develop a financial and budgetary plan of our operations while ensuring the company stays within our annual budget.I ensure the business has the materials and supplies it needs in order perform day-to-day functions by creating and maintaining a good relationship with vendors and suppliers to secure a reliable supply chain.
-
-
-
Carleton University Students' Association, Inc.
-
Canada
-
Non-profit Organizations
-
1 - 100 Employee
-
Hatch - Business Mentor
-
Sep 2017 - Apr 2020
Hatch, is a student-led entrepreneurship program dedicated to providing its members with entrepreneurial options through social and business networking within and outside of Carleton University.• Organize Google startup weekends, workshops, and keynote speeches given by leading public figures in the industry such as: Arlene Dickinson, Frank O’dea, and the Mayor of Ottawa • Connect budding entrepreneurs with investors, potential partners and their peers• Provide students with educational resources, mentorship, and grants to fuel their entrepreneurial ventures• Create web content on entrepreneurial skills, leadership, and academic excellence
-
-
-
National Research Council Canada / Conseil national de recherches Canada
-
Canada
-
Research Services
-
700 & Above Employee
-
Market and Scientific Analyst
-
Jan 2019 - May 2019
I completed a 4-month co-op term at the department of human health therapeutics. This department is responsible for creating and discovering innovative medicines capable of treating chronic diseases as well as facilitate the growth of Canadian Biotech SMEs.I compared and contrasted NRC’s technologies to their competitors, and wrote an extensive report describing each companies’ technologies, partnerships, and valuated their pipeline. Researched and proposed a new scalable manufacturing process for AAV vectors to eliminate cost and increase production yields. I obtained an understanding of the biopharmaceutical industry, and therapeutics such as single domain antibodies, AAV vectors, CAR T-cell therapy, and blood-brain barrier transporters.
-
-
-
National Research Council Canada / Conseil national de recherches Canada
-
Canada
-
Research Services
-
700 & Above Employee
-
Biotechnology Internship
-
Oct 2018 - Nov 2018
I was selected among the top biotechnology undergraduates from Carleton University to participate in a 3 day intensive biotechnology internship organized by the National Research Council of Canada (NRC). The purpose of this internship was to develop a cancer therapeutic and then pitch our drug to a panel of judges as a biotechnology start-up.I had the opportunity to participate in a series of engaging workshops from leading scientists at the NRC who specialize in the development and manufacturing of biologic therapeutics. These workshops included topics such as: • Single Antibody Domain Design and production• Drug Design and Production• Intellectual Property• Bio-manufacturing ( Purification, Biophysical Analysis, Bio-analysis).By the end of the 3 day Internship my team were proud to present our hypothetical start up company called Neuroblast which is a biologic's company that creates therapeutics for patients with high risk Neuroblastoma. The drug we proposed was a bi-specific single domain antibody which targeted over expressed GP2 and GPC2 proteins on the surface of Neuroblastoma cells. The string of 2 single domain antibodies would also be linked to a crossing agent which would allow it to cross the blood-brain barrier. Cancer cells would be killed by a radioisotope attached to the protein. The specificity of the single domain antibodies would allow for targeted killing of cancer cells without affecting healthy cells. As a result of our work, we were announced as the winners of the competition for best cancer therapeutic and business plan.
-
-
Education
-
2017 - 2021
Carleton University
Bachelor of Science - BSc, Biotechnology & Biology
Community
